Phase II trial of combined modality therapy (cmt) with myeloid growth factors in patients with locally advanced non-small cell lung cancer (NSCLC)
2008 ◽
Vol 26
(15_suppl)
◽
pp. 7567-7567
Keyword(s):
Phase Ii
◽